IGF2BP3 and colorectal carcinoma: As shown in Figure 7A, analysis indicated that, in the GSE110224 and TCGA CRC cohort, the SLC2A1 expression was remarkably positively associated with IGF2BP3 and YTHDF1 (p < 0.05).